Monoclonal Gammopathy of Renal Significance (MGRS) - Case Series from a Tertiary Center in Kerala

Indian J Nephrol. 2024 Jan-Feb;34(1):59-63. doi: 10.4103/ijn.ijn_329_22. Epub 2023 Mar 20.

Abstract

Monoclonal gammopathy of renal significance (MGRS) has gained importance because identifying the monoclonal deposit and addressing it, rather than treating renal dysfunction as the primary pathology, has salvaged the patients from progressing into end-stage renal disease. Since it affects elderly population, there could be a propensity to misdiagnose them with cardiorenal syndrome. We present four patients of MGRS diagnosed from our center. They presented with proteinuria or unexplained renal dysfunction. Three of the patients were diagnosed to have amyloidosis, of which two had lambda-type and one had kappa amyloidosis. The fourth patient had fibrillary glomerulonephritis with kappa restriction, further evaluation of which led to diagnosis of chronic lymphocytic leukemia. Absence of "M" band in protein electrophoresis and a normal bone marrow study should not stop physicians from further evaluation. Quantitative serum immunofixation electrophoresis and electron microscopic examination of renal biopsy have become a comprehensive diagnostic tool in such patients.

Keywords: Fibrillary glomerulonephritis; kappa amyloidosis; monoclonal gammopathy of renal significance (MGRS); serum immunofixation electrophoresis.

Publication types

  • Case Reports

Grants and funding

Financial support and sponsorship